Contract Services Contract Manufacturing
WuXi Biologics and Medigene Forge Strategic Partnership to Advance TCR-Guided T Cell Engagers for Cancer Treatment
Partnership leverages Medigene's leadership for T cell receptor (TCR) generation and characterization and WuXi Biologics' unique anti-CD3 mAb, its T cell...
August 09, 2024 | News
NEC Bio Therapeutics and AGC Biologics Partner to Enhance Production of Personalized Cancer Vaccine
NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria-based D...
August 08, 2024 | News
Andelyn Biosciences Partners with Broad Institute to Enhance Gene Therapy Platform with MyoAAV Plasmids
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entere...
August 07, 2024 | News
Samsung Biologics Joins PSCI to Enhance Responsible Supply Chain Management
Samsung Biologics to embed PSCI principles into business practices for responsible value chain management Supplier Partnership reaffirms company's commi...
August 07, 2024 | News
WuXi Biologics Secures EMA GMP Certification for Five Facilities in China
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that four manufacturing facilities ...
August 02, 2024 | News
Porton Advanced and Geneseed Biotech Forge Strategic Partnership to Accelerate circRNA Therapies
Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Bio...
July 31, 2024 | News
Agilent Acquires BIOVECTRA for $925 Million, Expanding Biopharma Capabilities
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing...
July 23, 2024 | News
CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Full-Life Technologies and SK Biopharmaceuticals Ink $571.5 Million Deal for Exclusive Rights to Radiopharmaceutical FL-091
Full-Life Technologies ("Full-Life"), a fully integrated global radiotherapeutics company, announced that it has entered into a license agreement wit...
July 17, 2024 | News
LOTTE BIOLOGICS Breaks Ground on Inaugural Plant at Songdo Bio Campus
LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheo...
July 05, 2024 | News
Porton Advanced Integrates MaxCyte cGMP-Grade Electroporation System into Cell Therapy Platform
Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as ...
June 26, 2024 | News
Celonic Group Expands Biologics Process Development with New Basel Facility
The Celonic Group, a “Pure Play” Biologics Contract Development Organization (CDMO) expands process development and optimization services in ...
June 19, 2024 | News
Bespak Expands Low GWP Inhaler Production with New High-Speed Filling Equipment
Bespak, a leading contract development and manufacturing organisation (CDMO) focused on orally inhaled and nasal drug-device combination products, is today...
June 12, 2024 | News
Aragen Bioscience and Getinge Validate Single-Use Production Reactors for Large-Scale Recombinant Antibody Production
Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish...
June 05, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
